Business Description
Pacific Edge Ltd
ISIN : NZPEBE0002S1
Total Employee Number:
34Description
Pacific Edge Ltd is a New Zealand-based company involved in researching, developing, and commercialising new diagnostic and prognostic tools for the early detection and management of cancers. It manages and operates the laboratories used for the detection of bladder cancer. It operates in two segments: Commercial, which includes sales, marketing, laboratory, and support operations to run the commercial businesses internationally; and Research, which is into research and development of diagnostic and prognostic products for human cancer. The commercial segment contributes to the majority of the revenue. Pacific Edge has a product in the marketplace called Cxbladder. Its geographical segments are the United States, which generates maximum revenue, New Zealand, and the Rest of the World.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 6.05 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | -0.04 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 2.35 | |||||
Beneish M-Score | -4.69 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -20.6 | |||||
3-Year EBITDA Growth Rate | 0.8 | |||||
3-Year EPS without NRI Growth Rate | -4.8 | |||||
3-Year FCF Growth Rate | 1 | |||||
3-Year Book Growth Rate | -53.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 48.11 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 82.29 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 53.55 | |||||
9-Day RSI | 55.79 | |||||
14-Day RSI | 59.05 | |||||
3-1 Month Momentum % | 55.17 | |||||
6-1 Month Momentum % | 40.63 | |||||
12-1 Month Momentum % | 134.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.02 | |||||
Quick Ratio | 1.72 | |||||
Cash Ratio | 1.14 | |||||
Days Sales Outstanding | 81.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.1 | |||||
Shareholder Yield % | -4.76 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -339.71 | |||||
Net Margin % | -311.14 | |||||
EBITDA Margin % | -321.85 | |||||
FCF Margin % | -280.4 | |||||
OCF Margin % | -279.25 | |||||
ROE % | -168.66 | |||||
ROA % | -120.2 | |||||
ROIC % | -585.83 | |||||
3-Year ROIIC % | 464.59 | |||||
ROC (Joel Greenblatt) % | -764.89 | |||||
ROCE % | -178.9 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 25.94 | |||||
PB Ratio | 31.12 | |||||
Price-to-Tangible-Book | 25 | |||||
EV-to-EBIT | -9.53 | |||||
EV-to-EBITDA | -10.06 | |||||
EV-to-Forward-EBITDA | 1270.29 | |||||
EV-to-Revenue | 32.37 | |||||
EV-to-Forward-Revenue | 30.78 | |||||
EV-to-FCF | -11.61 | |||||
Price-to-GF-Value | 5 | |||||
Price-to-Median-PS-Value | 0.93 | |||||
| Price-to-Net-Current-Asset-Value | 25 | |||||
Earnings Yield (Greenblatt) % | -10.49 | |||||
FCF Yield % | -8.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pacific Edge Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 9.929 | ||
| EPS (TTM) (A$) | -0.033 | ||
| Beta | -0.885 | ||
| 3-Year Sharpe Ratio | 0.46 | ||
| 3-Year Sortino Ratio | 0.82 | ||
| Volatility % | 82.64 | ||
| 14-Day RSI | 59.05 | ||
| 14-Day ATR (A$) | 0.008656 | ||
| 20-Day SMA (A$) | 0.248 | ||
| 12-1 Month Momentum % | 134.38 | ||
| 52-Week Range (A$) | 0.085 - 0.265 | ||
| Shares Outstanding (Mil) | 1,241.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pacific Edge Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pacific Edge Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2026-11-25 11:00 | In 149 days | ||
| Second quarter earnings results for 2027 | 2026-11-25 10:00 | In 149 days | ||
| General meeting for 2026 | 2026-08-06 15:00 | In 38 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-05-25 11:00 | 0.21 (-6.67%) | ||
| Annual report for 2026 | 2026-05-25 | 0.21 (-6.67%) | ||
| Fourth quarter earnings results for 2026 | 2026-05-25 | 0.21 (-6.67%) | ||
| Second quarter earnings conference call for 2026 | 2025-11-25 11:00 | 0.15 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2025-11-25 10:00 | 0.15 (+0.00%) | ||
| General meeting for 2025 | 2025-08-06 15:00 | 0.10 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2025-05-30 11:00 | 0.08 (+0.00%) |
Show
Entries
Pacific Edge Ltd Frequently Asked Questions
What is Pacific Edge Ltd(ASX:PEB)'s stock price today?
The current price of ASX:PEB is A$0.25. The 52 week high of ASX:PEB is A$0.27 and 52 week low is A$0.09.
When is next earnings date of Pacific Edge Ltd(ASX:PEB)?
The next earnings date of Pacific Edge Ltd(ASX:PEB) is 2026-11-25 Est..
Does Pacific Edge Ltd(ASX:PEB) pay dividends? If so, how much?
Pacific Edge Ltd(ASX:PEB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Pacific Edge Ltd
No articles.